{"id":"NCT01702454","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345","officialTitle":"Immunogenicity, Safety and Reactogenicity Study of GSK Biologicals' Quadrivalent Seasonal Influenza Candidate Vaccine GSK2321138A, Administered to Children Who Previously Participated in Study 115345","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10-06","primaryCompletion":"2013-05-06","completion":"2013-06-05","firstPosted":"2012-10-08","resultsPosted":"2014-07-14","lastUpdate":"2018-09-07"},"enrollment":470,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Fluarix Quadrivalent","otherNames":[]}],"arms":[{"label":"Fluarix Quadrivalent Primed Group","type":"EXPERIMENTAL"},{"label":"Fluarix Quadrivalent Unprimed Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the safety and immunogenicity of GSK Biologicals' investigational vaccine GSK2321138A in children who previously participated in study 115345 (FLU D-QIV-004 PRI) (NCT01439360).","primaryOutcome":{"measure":"Serum Hemagglutination Inhibition (HI) Antibody Titers Against Each of the Four Vaccine Strains After 1 Dose of Fluarix Quadrivalent Vaccine","timeFrame":"At Day 0 and Day 7","effectByArm":[{"arm":"Fluarix Quadrivalent Primed Group","deltaMin":43.1,"sd":null},{"arm":"Fluarix Quadrivalent Unprimed Group","deltaMin":14.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"17 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":12},"locations":{"siteCount":33,"countries":["Czechia","Poland","Spain","United Kingdom"]},"refs":{"pmids":["30325891"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":241},"commonTop":["Pain","Irritability/Fussiness","Redness","Drowsiness","Loss of Appetite"]}}